Effects of Garcinia cambogia (hydroxycitric acid) on visceral fat accumulation:: A double-blind, randomized, placebo-controlled trial

被引:70
作者
Hayamizu, K
Ishii, Y
Kaneko, I
Shen, MZ
Okuhara, Y
Shigematsu, N
Tomi, H
Furuse, M
Yoshino, G
Shimasaki, H
机构
[1] FANCL Corp, Cent Res Lab, Totsuka Ku, Kanagawa 2440806, Japan
[2] Kyushu Univ, Fac Agr, Lab Adv Anim & Marine Bioresources, Fukuoka 812, Japan
[3] Nippon Shinyaku Co Ltd, Food Dev Lab, Kyoto 601, Japan
[4] Univ Tokyo, Sch Med, Dept Lab Med, Tokyo 113, Japan
[5] Teikyo Univ, Sch Med, Dept Biochem, Tokyo 173, Japan
来源
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 2003年 / 64卷 / 08期
关键词
Garcinia cambogia; hydroxycitric acid; visceral fat accumulation; computed tomography scan;
D O I
10.1016/j.curtheres.2003.08.006
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: (-)Hydroxycitric acid (HCA) is an active ingredient extracted from the rind of the Indian fruit Garcinia cambogia. It inhibits adenosine triphosphate citrate lyase and has been used in the treatment of obesity. Objective: The primary end point of this study was the effects of 12 weeks of G cambogia extract administration on visceral fat accumulation. The secondary end points were body indices (including height, body weight, body mass index [BMI], waist and hip circumference, and waist-hip ratio) and laboratory values (including total cholesterol, triacylglycerol, and free fatty acid). Methods: This study was performed according to a double-blind, randomized, placebo-controlled, parallel-group design. Subjects aged 20 to 65 years with a visceral fat area >90 cm(2) were enrolled. Subjects were randomly assigned to receive treatment for 12 weeks with G cambogia (containing 1000 mg of HCA per day) or placebo. At the end of the treatment period, both groups were administered placebo for 4 weeks to assess any rebound effect. Each subject underwent a computed tomography scan at the umbilical level at -2, 0, 12, and 16 weeks. Results: Forty-four subjects were randomized at baseline, and 39 completed the study (G cambogia group, n = 18; placebo group, n = 21). At 16 weeks, the G cambogia group had significantly reduced visceral, subcutaneous, and total fat areas compared with the placebo group (all indices P < 0.001). No severe adverse effect was observed at any time in the test period. There were no significant differences in BMI or body weight at week 12, but there were slight numeric decreases in body weight and BMI in men. There were no signs of a rebound effect from week 12 to week 16. Conclusion: G cambogia reduced abdominal fat accumulation in subjects, regardless of sex, who had the visceral fat accumulation type of obesity. No rebound effect was observed. It is therefore expected that G cambogia may be useful for the prevention and reduction of accumulation of visceral fat.
引用
收藏
页码:551 / 567
页数:17
相关论文
共 34 条
[2]   THE EFFECT OF (-)-HYDROXYCITRATE ON THE ACTIVITY OF THE LOW-DENSITY-LIPOPROTEIN RECEPTOR AND 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE LEVELS IN THE HUMAN HEPATOMA-CELL LINE HEP G2 [J].
BERKHOUT, TA ;
HAVEKES, LM ;
PEARCE, NJ ;
GROOT, PHE .
BIOCHEMICAL JOURNAL, 1990, 272 (01) :181-186
[3]   COMPLICATIONS OF OBESITY [J].
BRAY, GA .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (06) :1052-1062
[4]  
Conte A.A., 1993, AM J BARIATR MED SUM, P17
[5]  
Despres Jean-Pierre, 1993, Nutrition Research Reviews, V6, P137, DOI 10.1079/NRR19930010
[6]  
Hayamizu K., 2001, J OLEO SCI, V50, P805, DOI [10.5650/jos.50.805, DOI 10.5650/JOS.50.805]
[7]   Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent -: A randomized controlled trial [J].
Heymsfield, SB ;
Allison, DB ;
Vasselli, JR ;
Pietrobelli, A ;
Greenfield, D ;
Nunez, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (18) :1596-1600
[8]   OBESITY AS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR-DISEASE - A 26-YEAR FOLLOW-UP OF PARTICIPANTS IN THE FRAMINGHAM HEART-STUDY [J].
HUBERT, HB ;
FEINLEIB, M ;
MCNAMARA, PM ;
CASTELLI, WP .
CIRCULATION, 1983, 67 (05) :968-977
[9]   Body weight, cardiovascular risk factors, and coronary mortality - 15-year follow-up of middle-aged men and women in eastern Finland [J].
Jousilahti, P ;
Tuomilehto, J ;
Vartiainen, E ;
Pekkanen, J ;
Puska, P .
CIRCULATION, 1996, 93 (07) :1372-1379
[10]  
KENO Y, 1991, INT J OBESITY, V15, P205